These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1164 related items for PubMed ID: 24118778

  • 21. Role of hepatitis B viral load and basal core promoter mutation in hepatocellular carcinoma in hepatitis B carriers.
    Liu CJ, Chen BF, Chen PJ, Lai MY, Huang WL, Kao JH, Chen DS.
    J Infect Dis; 2006 May 01; 193(9):1258-65. PubMed ID: 16586363
    [Abstract] [Full Text] [Related]

  • 22. Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles.
    Lee MH, Yang HI, Liu J, Batrla-Utermann R, Jen CL, Iloeje UH, Lu SN, You SL, Wang LY, Chen CJ, R.E.V.E.A.L.-HBV Study Group.
    Hepatology; 2013 Aug 01; 58(2):546-54. PubMed ID: 23504622
    [Abstract] [Full Text] [Related]

  • 23. Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levels.
    Yuen MF, Tanaka Y, Shinkai N, Poon RT, But DY, Fong DY, Fung J, Wong DK, Yuen JC, Mizokami M, Lai CL.
    Gut; 2008 Jan 01; 57(1):98-102. PubMed ID: 17483190
    [Abstract] [Full Text] [Related]

  • 24. Association of cytokine and DNA repair gene polymorphisms with hepatitis B-related hepatocellular carcinoma.
    Chen CC, Yang SY, Liu CJ, Lin CL, Liaw YF, Lin SM, Lee SD, Chen PJ, Chen CJ, Yu MW.
    Int J Epidemiol; 2005 Dec 01; 34(6):1310-8. PubMed ID: 16172101
    [Abstract] [Full Text] [Related]

  • 25. Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma.
    Chou YC, Yu MW, Wu CF, Yang SY, Lin CL, Liu CJ, Shih WL, Chen PJ, Liaw YF, Chen CJ.
    Gut; 2008 Jan 01; 57(1):91-7. PubMed ID: 17502344
    [Abstract] [Full Text] [Related]

  • 26. Mutational complex genotype of the hepatitis B virus X /precore regions as a novel predictive marker for hepatocellular carcinoma.
    Jang JW, Chun JY, Park YM, Shin SK, Yoo W, Kim SO, Hong SP.
    Cancer Sci; 2012 Feb 01; 103(2):296-304. PubMed ID: 22136288
    [Abstract] [Full Text] [Related]

  • 27. Association of HLA-DRB1*13 and TNF-alpha gene polymorphisms with clearance of chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai population.
    Kummee P, Tangkijvanich P, Poovorawan Y, Hirankarn N.
    J Viral Hepat; 2007 Dec 01; 14(12):841-8. PubMed ID: 18070287
    [Abstract] [Full Text] [Related]

  • 28. A functional polymorphism in pre-microRNA-196a-2 contributes to the susceptibility of hepatocellular carcinoma in a Turkish population: a case-control study.
    Akkız H, Bayram S, Bekar A, Akgöllü E, Ulger Y.
    J Viral Hepat; 2011 Jul 01; 18(7):e399-407. PubMed ID: 21692953
    [Abstract] [Full Text] [Related]

  • 29. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men.
    Yu MW, Yeh SH, Chen PJ, Liaw YF, Lin CL, Liu CJ, Shih WL, Kao JH, Chen DS, Chen CJ.
    J Natl Cancer Inst; 2005 Feb 16; 97(4):265-72. PubMed ID: 15713961
    [Abstract] [Full Text] [Related]

  • 30. Genetic variants in human leukocyte antigen/DP-DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development.
    Hu L, Zhai X, Liu J, Chu M, Pan S, Jiang J, Zhang Y, Wang H, Chen J, Shen H, Hu Z.
    Hepatology; 2012 May 16; 55(5):1426-31. PubMed ID: 22105689
    [Abstract] [Full Text] [Related]

  • 31. Virological and clinical implication of core promoter C1752/V1753 and T1764/G1766 mutations in hepatitis B virus genotype D infection in Mongolia.
    Elkady A, Tanaka Y, Kurbanov F, Oynsuren T, Mizokami M.
    J Gastroenterol Hepatol; 2008 Mar 16; 23(3):474-81. PubMed ID: 18318825
    [Abstract] [Full Text] [Related]

  • 32. Different pre-S deletion patterns and their association with hepatitis B virus genotypes.
    Chen BF.
    World J Gastroenterol; 2016 Sep 21; 22(35):8041-9. PubMed ID: 27672298
    [Abstract] [Full Text] [Related]

  • 33. Role of hepatitis B virus precore/core promoter mutations and serum viral load on noncirrhotic hepatocellular carcinoma: a case-control study.
    Liu CJ, Chen BF, Chen PJ, Lai MY, Huang WL, Kao JH, Chen DS.
    J Infect Dis; 2006 Sep 01; 194(5):594-9. PubMed ID: 16897657
    [Abstract] [Full Text] [Related]

  • 34. Clinical significance of pre-S mutations in patients with genotype C hepatitis B virus infection.
    Choi MS, Kim DY, Lee DH, Lee JH, Koh KC, Paik SW, Rhee JC, Yoo BC.
    J Viral Hepat; 2007 Mar 01; 14(3):161-8. PubMed ID: 17305881
    [Abstract] [Full Text] [Related]

  • 35. Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients.
    Chen CH, Hung CH, Lee CM, Hu TH, Wang JH, Wang JC, Lu SN, Changchien CS.
    Gastroenterology; 2007 Nov 01; 133(5):1466-74. PubMed ID: 17915220
    [Abstract] [Full Text] [Related]

  • 36. Association study of microRNA polymorphisms with hepatocellular carcinoma in Korean population.
    Kim WH, Min KT, Jeon YJ, Kwon CI, Ko KH, Park PW, Hong SP, Rim KS, Kwon SW, Hwang SG, Kim NK.
    Gene; 2012 Aug 01; 504(1):92-7. PubMed ID: 22583825
    [Abstract] [Full Text] [Related]

  • 37. A p53 polymorphism modifies the risk of hepatocellular carcinoma among non-carriers but not carriers of chronic hepatitis B virus infection.
    Zhu ZZ, Cong WM, Liu SF, Xian ZH, Wu WQ, Wu MC, Gao B, Hou LF, Zhu GS.
    Cancer Lett; 2005 Nov 08; 229(1):77-83. PubMed ID: 15979781
    [Abstract] [Full Text] [Related]

  • 38. Prevalence of hepatocarcinoma-related hepatitis B virus mutants in patients in grey zone of treatment.
    Gil-García AI, Madejón A, Francisco-Recuero I, López-López A, Villafranca E, Romero M, García A, Olveira A, Mena R, Larrubia JR, García-Samaniego J.
    World J Gastroenterol; 2019 Oct 14; 25(38):5883-5896. PubMed ID: 31636479
    [Abstract] [Full Text] [Related]

  • 39. Genetic variability of hepatitis B and C viruses in Brazilian patients with and without hepatocellular carcinoma.
    Araujo OC, Barros JJ, do Ó KM, Nabuco LC, Luz CA, Perez RM, Niel C, Villela-Nogueira CA, Araujo NM.
    J Med Virol; 2014 Feb 14; 86(2):217-23. PubMed ID: 24338810
    [Abstract] [Full Text] [Related]

  • 40. Association of a variant in MIR 196A2 with susceptibility to hepatocellular carcinoma in male Chinese patients with chronic hepatitis B virus infection.
    Qi P, Dou TH, Geng L, Zhou FG, Gu X, Wang H, Gao CF.
    Hum Immunol; 2010 Jun 14; 71(6):621-6. PubMed ID: 20188135
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 59.